Finalists announced for OBN Awards 2016
OBN is delighted to announce the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic Biology and Digital Health.
The OBN Awards remain proudly independent, celebrating innovation and achievement across the UK life sciences industry and recognising achievements from emerging to late stage R&D companies as well as life sciences investors.
A judging panel comprising a range of industry experts has been assembled to decide the overall winner in each category, with the winning companies being announced at the OBN Awards Ceremony on Thursday 6th October at the Oxford Town Hall.
John Harris, CEO of OBN, commented: "We are delighted with the great number of quality entries we received this year, in particular the Best Start-Up Biotech, Best Start-Up Medtech and the Best Implementation of Digital Healthcare Award categories. We are looking forward to celebrating some exciting new businesses and sharing some impressive achievements across the industry at our Awards in October."
Best Start-up Biotech Company Award:
Kindly sponsored by Penningtons Manches
Best Emerging Biotech Company Award:
Kindly Sponsored by Covance
Best Established Biotech Company Award:
Kindly sponsored by Premier Research
Best Start-up Medtech Company Award:
Kindly Sponsored by JA Kemp
Best Emerging Medtech Company Award:
Kindly sponsored by World Courier
Best Established Medtech Company Award:
Kindly sponsored by Arthur J Gallagher
Best Emerging UK Synthetic Biotech Company Award:
Kindly sponsored by SynbiCITE
Best Implementation of Digital Healthcare Award:
Kindly sponsored by EY
Best UK Life Sciences Incubator Award:
Kindly sponsored by James Cowper Kreston
Highest Impact Investor Award:
Individual tickets for the awards on Thursday 6th October are still available, to book please visit www.obn-awards.com